FDA seeks injunction to stop two stem cell companies after patients blinded

The Food and Drug Administration is asking federal courts on opposite sides of the country to permanently stop two stem cell companies from operating after reports of patients being blinded by their treatments.

In a statement Wednesday announcing the injunction request, the FDA said U.S. Stem Cell Clinic in Florida, the Cell Surgical Network in California and others like them are exploiting patients desperate for cures and causing some of them “serious and permanent harm.” The agency said both companies “have continued to disregard the law” and marketed products without regulatory approval.

Hundreds of such clinics have popped up across the country in recent years, many promoting treatments for conditions including Parkinson’s disease, autism and multiple sclerosis. Federal regulators have



You Might Like
Learn more about RevenueStripe...

Health, science and environment news from The Washington Post.